Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,068 across all filing types
Latest filing 2026-01-02 Capital/Financing Update
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Vivesto publishes information document regarding the rights issue
Capital/Financing Update Classification · 98% confidence The document is a press release announcing the publication of an 'information document' regarding a rights issue. It provides details about the rights issue, such as the subscription price, timeline, and use of proceeds, but explicitly states that it is not a prospectus and that the actual information document is available via a link. Following the 'Menu vs Meal' rule, since this is an announcement of a report/document rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2026-01-02 English
Kommuniké från extra bolagsstämma i Vivesto AB
AGM Information Classification · 98% confidence The document is a 'Kommuniké från extra bolagsstämma' (Communiqué from an Extraordinary General Meeting) for Vivesto AB. It details the decisions made at the meeting, specifically regarding a rights issue (nyemission), changes to the articles of association, and approval of guarantee commitments. While it reports on the meeting's outcomes, it is a short announcement (under 5,000 characters) that concludes with a link to the full meeting documents ('Bifogade filer'). Therefore, it functions as a report publication announcement regarding the meeting results.
2025-12-22 Swedish
Report from Extraordinary General Meeting in Vivesto AB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a report detailing the resolutions passed at an Extraordinary General Meeting (EGM) of Vivesto AB. It covers specific voting outcomes regarding share issues, amendments to articles of association, and guarantee undertakings. While it mentions the meeting took place, it provides the actual results of the votes and resolutions, which aligns with the definition of a Declaration of Voting Results (DVA).
2025-12-22 English
Notice of Extraordinary General Meeting in Vivesto AB
Regulatory Filings
2025-11-20 English
Kallelse till extra bolagsstämma i Vivesto AB
AGM Information Classification · 100% confidence The document is a detailed notice (kallelse) for an extraordinary general meeting (extra bolagsstämma) of Vivesto AB, scheduled for December 22, 2025. It includes information on the meeting agenda, participation rights, proxy voting, and detailed proposals for decisions to be made at the meeting, including amendments to the articles of association and approval of a rights issue (nyemission) with pre-emptive rights for existing shareholders. The document is a formal meeting notice and proposal document, not a report or financial statement. It is not an announcement of voting results, nor a proxy solicitation statement, but a call to shareholders to attend and vote on specific matters. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting. The document length (15,000 characters) and content confirm it is the meeting notice and agenda, not a brief announcement or a report publication announcement.
2025-11-20 Swedish
Vivesto resolves on a fully secured rights issue of approximately SEK 53.8 million, subject to approval by an Extraordinary General Meeting
Regulatory Filings
2025-11-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.